The part of Teva Pharmaceutical Industries Ltd. (NYSE: all;; Level: Teva) The flowing water recently while two Israeli investors have become parties interested in the company. Last week Teva reported that Menora Mivtachim (Tase: mmhd) holds 5% company stake and is currently reported with a similar stake.
Related articles
In the current price of Teva’s stock, it is a hold worth about $ 933 million for each of the Israeli and financial insurance companies. With two Israeli companies, the US Asset Meeting (FMR) is also a Party interested in Teva with 7.1% holders. Because it’s passive holds, institutions need not be specified in which prices they have purchased in parts.
Teva, who was governed by CEO Richard Francis, traded in New York and Tel Aviv Stock Epchanges, with a market cap of $ 18.7 billion. Since the beginning of the year, the stock falls 26% after doubling in 2024.
The company will publish the financial report for the second quarter next week of July 30. The analysts in a way) compared to the streamlining of the 2% of the workers in 2027. The Teva provides a day invested for the new sector.
Like today, most analysts covering stocks positively, and their average target price is 44% higher than the current NYSE price.
Published in Globes, Israel News in News – en.globes.co.il – On July 22, 2025.
© Copyright in Globes Publisher Itonut (1983) Ltd., 2025.
